Evidence map›Paper›PMID 41948271›Full record

ArticleCureus2026

Effect of Opioid-Sparing Multimodal Anesthesia Within an Enhanced Recovery After Surgery (ERAS) Protocol on Postoperative Recovery in Gynecologic Oncology Surgery: A Randomized Clinical Study.

Maria Bourazani, Nikolaos Fyrfiris, Petros Galanis, Chrysseida Maglari, Antonios Anagnostopoulos, Dimitrios C Papatheodorou, Martha Kelesi, Sofia Poulopoulou

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maria BourazaniDepartment of Anaesthesiology, Hellenic Anticancer Institute, Saint Savvas Hospital, Athens, GRC.
Nikolaos FyrfirisDepartment of Anaesthesiology, Hellenic Anticancer Institute, Saint Savvas Hospital, Athens, GRC.
Petros GalanisClinical Epidemiology Laboratory, Faculty of Nursing, National and Kapodistrian University of Athens, Athens, GRC.
Chrysseida MaglariDepartment of Anaesthesiology, Hellenic Anticancer Institute, Saint Savvas Hospital, Athens, GRC.
Antonios AnagnostopoulosDepartment of Gynecologic Oncology, Hellenic Anticancer Institute, Saint Savvas Hospital, Athens, GRC.
Dimitrios C PapatheodorouDepartment of Gynecologic Oncology, Hellenic Anticancer Institute, Saint Savvas Hospital, Athens, GRC.
Martha KelesiDepartment of Nursing, University of West Attica, Athens, GRC.
Sofia PoulopoulouDepartment of Anaesthesiology, Hellenic Anticancer Institute, Saint Savvas Hospital, Athens, GRC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMajor gynecologic oncological procedures are associated with moderate to severe postoperative pain and significant morbidity. Opioids remain a cornerstone of postoperative analgesia but are frequently linked with adverse effects that may delay recovery. Enhanced Recovery After Surgery (ERAS) protocols emphasize multimodal analgesia strategies aimed at minimizing opioid use while improving recovery outcomes. The aim of this study was to evaluate whether an opioid-sparing multimodal anesthesia protocol within an ERAS pathway improves postoperative outcomes in patients undergoing gynecologic oncologic surgery.

methodsThis randomized clinical study included 101 women undergoing major gynecologic oncological procedures. Fifty-one patients were allocated to an ERAS protocol incorporating multimodal anesthesia and opioid-sparing strategies, while 50 patients received conventional perioperative care. Standardized anesthesia management was applied in both groups, with the ERAS group receiving additional multimodal interventions including perioperative magnesium, structured antiemetic prophylaxis, early oral intake, and early transition to oral analgesia. Pain scores, rescue analgesic use, postoperative complications, time to oral intake, gastrointestinal recovery, and discontinuation of intravenous therapy were analyzed.

resultsPatients managed under the ERAS protocol demonstrated significantly lower postoperative pain scores at all measured time points compared with controls (p < 0.001). Rescue analgesic requirements were significantly reduced in the ERAS group (p < 0.001). Early oral feeding within six hours occurred significantly more frequently in the ERAS group than in the control group (p < 0.001). Gastrointestinal recovery and early discontinuation of intravenous therapy were also significantly improved in the ERAS group (p < 0.001). Additionally, ERAS patients exhibited lower incidences of vomiting, sedation, and somnolence postoperatively (p = 0.01, p = 0.01, and p = 0.001, respectively).

conclusionsImplementation of an opioid-sparing multimodal anesthesia strategy within an ERAS pathway significantly improves postoperative recovery in gynecologic oncologic surgery. The protocol reduces opioid-related adverse effects, enhances gastrointestinal recovery, and supports earlier mobilization and oral intake. These findings reinforce the role of multimodal anesthesia as a key component of ERAS programs in oncological surgery.

Indexed as

eraseras protocolsgynecologic oncologygynecologic oncology surgerymultimodal analgesiaopioid-sparing analgesiapostoperative recovery

Identifiers

PMID41948271
PMCPMC13052719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.